ARRIVENT BIOPHARMA INC (AVBP) Stock Analyst Ratings
NASDAQ:AVBP • US04272N1028
22.99 USD
-0.1 (-0.43%)
At close: Feb 20, 2026
23.5 USD
+0.51 (+2.22%)
After Hours: 2/20/2026, 8:17:49 PM
ChartMill assigns a Buy % Consensus number of 86% to AVBP. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 41.57. This target is 80.8% above the current price.
- AVBP was analyzed by 19 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about AVBP.
- In the previous month the buy percentage consensus was at a similar level.
- AVBP was analyzed by 19 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-12-23 | Cantor Fitzgerald | Initiate | Overweight |
| 2025-12-10 | BTIG | Initiate | Buy |
| 2025-11-25 | Truist Securities | Initiate | Buy |
| 2025-11-11 | Citigroup | Maintains | Buy -> Buy |
| 2025-08-12 | Citigroup | Maintains | Buy -> Buy |
| 2025-08-12 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-07-22 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-07-10 | Goldman Sachs | Reiterate | Buy |
| 2025-06-25 | Clear Street | Initiate | Buy |
| 2025-06-24 | Guggenheim | Reiterate | Buy -> Buy |
| 2025-06-24 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-05-20 | Jones Trading | Initiate | Buy |
| 2025-05-14 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-03-20 | B. Riley Securities | Initiate | Buy |
| 2025-03-10 | Guggenheim | Initiate | Buy |
| 2025-03-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-22 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-11-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-11 | Citigroup | Maintains | Buy -> Buy |
| 2024-09-10 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2024-09-10 | Goldman Sachs | Maintains | Buy -> Buy |
| 2024-09-10 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-08-16 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-08-15 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2024-06-06 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-09 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-30 | HC Wainwright & Co. | Initiate | Buy |
| 2024-02-20 | Goldman Sachs | Initiate | Buy |
| 2024-02-20 | Citigroup | Initiate | Buy |
| 2024-02-20 | Jefferies | Initiate | Buy |
ARRIVENT BIOPHARMA INC / AVBP FAQ
Can you provide the average price target for ARRIVENT BIOPHARMA INC stock?
19 analysts have analysed AVBP and the average price target is 41.57 USD. This implies a price increase of 80.8% is expected in the next year compared to the current price of 22.99.
What is the consensus rating for ARRIVENT BIOPHARMA INC (AVBP) stock?
The consensus rating for ARRIVENT BIOPHARMA INC (AVBP) is 86.3158 / 100 . This indicates that analysts generally have a positive outlook on the stock.